Ministerial Regulation No. 39 of 2018 on Procedures for Compulsory Patent Licensing took effect on 28 December 2018. This Regulation appears intended to provide a clear structure to compulsory licensing in accordance with TRIPS/the Doha Declaration. However it goes beyond that for reasons unknown so has caused an uproar in the pharma world.
Read more from Rouse Magazine: https://www.rouse.com/magazine/news/indonesia-compulsory-licensing-scare/?tag=indonesia